Anondita Medicare Secures ₹8.01 Crore CMSS Order for 8 Crore Condoms

Anondita Medicare Limited, an Indian manufacturer of condoms and sexual wellness products, has secured an ₹8.01-crore supply order from the Central Medical Services Society (CMSS) for supplying 8,00,62,000 condoms under the Government of India’s Family Planning Programme.

The company, listed on the NSE SME platform as ANONDITA, was earlier declared the L1 bidder under Schedule 1 for CMSS tender CMSS/Proc/2026-27/FP/005, dated May 6, 2026. The tender covers free condom supplies under the Ministry of Health and Family Welfare’s family-planning programme. Anondita disclosed its L1 status on August 31, followed by confirmation of the ₹8.01-crore supply order.

The scale of the contract highlights the continuing requirement for contraceptive supplies across India’s public-health system. CMSS functions as a central procurement agency under the Health Ministry and supports the purchase and distribution of healthcare commodities for government programmes. In 2023, the government said CMSS had procured 5.88 crore condoms for the Family Planning Programme.

The latest order comes as India’s family-planning programme increasingly focuses on reproductive health, informed contraceptive choice and accessibility. NFHS-5 data showed India’s contraceptive prevalence rate rising to 67%, while unmet need for family planning fell to around 9%. Initiatives such as Mission Parivar Vikas, launched in 2016, have sought to expand access to modern contraceptive methods.

For Anondita, the order comes amid rapid expansion. The company manufactures products under its flagship COBRA brand and has increased annual condom capacity to nearly 806 million pieces, according to management’s FY26 earnings call. It is also developing female condoms and expanding its manufacturing footprint.

The company reported FY26 consolidated revenue of ₹137.42 crore, up from ₹77.10 crore in FY25, while net profit rose from ₹16.40 crore to ₹36.15 crore. Its Q1 FY27 disclosed order inflow stood at ₹105.47 crore across six orders.

Anondita is also pursuing international markets. In May, it announced a ₹43.14-crore South African export order for male condoms under the country’s government procurement programme.

The latest CMSS contract therefore adds to a growing domestic and international order pipeline. However, the company’s ability to maintain margins, manage working capital, meet delivery schedules and execute large-volume contracts will remain key factors in converting order growth into sustainable financial performance.

Led by Managing Director Anupam Ghosh, Anondita says it remains focused on quality, compliance, manufacturing efficiency and expansion across domestic and international markets.